Miami, FL -- (ReleaseWire) -- 04/08/2014 -- Pennystocksites.com a leading online financial newsletter source, Reports on the following Companies: Acasti Pharma Inc. (NASDAQ:ACST), ZaZa Energy Corporation (NASDAQ:ZAZA), Comstock Holding Companies Inc. (NASDAQ:CHCI) and Vical Incorporated (NASDAQ:VICL).
Every day we scan the markets for the hottest stocks with the best potential for huge gains. Our vast network is second to none when it comes to delivering fast moving stocks and more importantly getting you out in front of them.
Join Us Here: http://pennystocksites.com/signups/
Acasti Pharma Inc. (NASDAQ:ACST) Acasti Pharma Inc., a biopharmaceutical company, focuses on the research, development, and commercialization of new therapies for abnormalities in blood lipids, and the treatment and prevention of cardiovascular disorders. The company offers Onemia, a medical food that is used in the dietary management of illnesses associated with omega-3 phospholipids deficiency related to cardiometabolic disorders. Its product development pipeline includes CaPre, a drug product candidate that is in Phase II clinical trial for the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia. The company was incorporated in 2002 and is headquartered in Laval, Canada. Acasti Pharma Inc. is a subsidiary of Neptune Technologies & Bioressources Inc.
Get a Free Technical Analysis on Acasti Pharma Inc. (NASDAQ:ACST): http://pennystocksites.com/market-scan/?symbol=acst
ZaZa Energy Corporation (NASDAQ:ZAZA) ZaZa Energy Corporation, together with its subsidiaries, focuses on the exploration and development of unconventional oil and gas resources in the United States. Its principal properties include Eagle Ford Shale located in Gonzales, Fayette, Dewitt, and Lavaca counties, Texas; and Eaglebine Shale situated in Madison, Grimes, and Walker counties, Texas. The company was founded in 2009 and is based in Houston, Texas.
Get a Free Technical Analysis on ZaZa Energy Corporation (NASDAQ:ZAZA): http://pennystocksites.com/market-scan/?symbol=zaza
Comstock Holding Companies Inc. (NASDAQ:CHCI) Comstock Holding Companies, Inc. operates as a real estate development and services company in the United States. The company operates through three segments: Homebuilding, Apartment Buildings, and Real Estate Services. The company builds apartments, single-family homes, townhouses, mid-rise condominiums, high-rise multi-family condominiums, and mixed-use residential and commercial developments. It also provides real estate management services, including strategic planning, land development, entitlement, property management, sales and marketing, workout and turnaround strategies, financing, and general construction services; and construction management, general contracting, and other real estate related services to other property owners. The company was formerly known as Comstock Homebuilding Companies, Inc. and changed its name to Comstock Holding Companies, Inc. in June 2012. Comstock Holding Companies, Inc. was founded in 1985 and is headquartered in Reston, Virginia.
Get a Free Technical Analysis on Comstock Holding Companies Inc. (NASDAQ:CHCI): http://pennystocksites.com/market-scan/?symbol=chci
Vical Incorporated (NASDAQ:VICL) Vical Incorporated is engaged in the research and development of biopharmaceutical products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), which completed preclinical trial to prevent infection before pregnancy to preclude fetal transmission; and therapeutic and prophylactic vaccines for herpes simplex virus type 2, which are under Phase 1/2 clinical trial to prevent and protect against recurring flare-ups, reduce viral shedding, and transmission. The company, through corporate collaborations, is also developing TransVax, which is in Phase III clinical trial to protect against CMV infection after stem cell transplants, as well as in Phase II clinical trial for prevention of CMV infection in kidney transplant recipients; and ONCEPT therapeutic cancer vaccine encoding human tyrosinase for the treatment to enhance survival time of dogs with oral melanoma. In addition, Vical Incorporated, through government collaboration, is developing Tetravalent dengue vaccine, a Phase I clinical trial product to prevent dengue disease caused by all four dengue serotypes. Further, it is also engaged in contract manufacturing of plasmid investigational products for various clients. The company was founded in 1987 and is headquartered in San Diego, California.
Get a Free Technical Analysis on Vical Incorporated (NASDAQ:VICL): http://pennystocksites.com/market-scan/?symbol=vicl
Disclosure: We are not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit http://pennystocksites.com/disclaimer/ for complete risks and disclosures.